Nicotinamide for early to moderate open-angle glaucoma
Part of Eyes & vision clinical trials.
This trial tests whether nicotinamide (a form of vitamin B3) can slow vision changes from open-angle glaucoma. It compares nicotinamide versus a placebo (inactive pill) in adults with early to moderate disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with open-angle glaucoma within the last 12 months, in at least one eye
- You are an adult (18 or older) and can give informed consent
- Your eye tests fit the trial range: open angle, and vision/field results are not too poor
- You can attend study visits and follow the study plan for the full study time
- If you could become pregnant, you must have a negative pregnancy test and use very effective birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether citicoline 2% eye drops can help slow worsening of the visual field in adults with open-angle glaucoma. If you qualify, you would be monitored with repeated eye tests to see if your vision field stays more stable over time.
This trial studies whether nicotinamide (a form of vitamin B3/niacin) can slow or affect glaucoma progression. You may be eligible if you have newly diagnosed, untreated glaucoma or if you have treated glaucoma with measurable visual field changes.
This trial tests whether a vitamin B3 supplement called nicotinamide can help slow down vision loss in people with glaucoma. It is for those with moderate disease who are already on treatment.
This study measures levels of nicotinamide (a form of vitamin B3) in different eye fluids of people with glaucoma and compares them to people without glaucoma. It aims to understand how nicotinamide relates to cell damage and aging in the eye, which could help develop new treatments.
This trial tests whether NAD precursor supplements can improve nerve health and vision in people with glaucoma. If you have glaucoma with mild to moderate vision loss, this study may help understand if these supplements could protect your optic nerve.
This study tests whether nicotinamide (vitamin B3) can slow or improve vision loss in people with a specific form of LHON. You may be able to join if your symptoms began recently and you have not taken certain other treatments.
Hear when a new Glaucoma, Open-Angle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.